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Abstract.  The glycolipid-binding cytotoxin produced 
by Shigella dysenteriae 1, Shiga toxin, binds to MDCK 
cells (strain  1) only after treatment with short-chain 
fatty acids like butyric acid or with the tumor pro- 
moter  12-O-tetradecanoylphorbol  13-acetate.  The in- 
duced binding sites were found to be functional with 
respect to endocytosis and translocation of toxin to the 
cytosol. Glycolipids that bind Shiga toxin appeared at 
both the apical and the basolateral surface of polarized 
MDCK cells grown on filters, and Shiga toxin was found 
to be endocytosed from both sides of the cells. This was 
demonstrated by EM of cells incubated with Shiga- 
HRP and by subcellular fractionation of cells in- 
cubated with  t25I-labeled Shiga toxin.  The data indi- 
cated that toxin molecules are endocytosed from coated 
pits,  and that some internalized  Shiga toxin is trans- 
ported to the Golgi apparatus.  Fractionation of pola- 
rized cells incubated with  125I-Shiga toxin showed that 
the transport of toxin to the Golgi apparatus was equally 
efficient from both poles of the cells. After 1-h incuba- 
tion at 37°C ~10%  of the internalized toxin was found 
in the Golgi fractions.  The results thus suggest that 
glycolipids can be efficiently transported to the Golgi 
apparatus  from both sides of polarized MDCK cell 
monolayers. 
S 
mGA  toxin  binds  to  glycolipids  with  the  structure 
galal-4gal expressed on some cell types (9, 20,  23; 
Mobassaleh, M., A. Donohue-Rolfe,  R. Montgomery, 
G. Keusch, and R. Grand.  1986. Pediatr. Res. 20:a245.) Li- 
gand binding apparently  induces redistribution  of the glyco- 
lipids into coated pits, and the toxin-glycolipid complex is 
subsequently internalized  (40).  Since Shiga toxin is firmly 
bound to glycolipids  and does not dissociate at low pH, it 
may serve as a marker of glycolipid uptake and intraceUular 
transport.  Compared to the large nUmber of studies on up- 
take,  sorting,  and transport of proteins,  relatively  little  is 
known about trafficking of  glycolipids and glycolipid-binding 
ligands. We therefore wished to extend our studies on Shiga 
toxin transport from cells grown on impermeable substrates 
(40) to polarized epithelial  cells. 
We have previously used MDCK cells grown on perme- 
able filters to study the uptake and transport of the toxic plant 
protein ricin (49).  MDCK cells do, however, normally not 
bind detectable amounts of Shiga toxin. As we show in this 
study, treatment  with butyric acid and the phorbol ester 12- 
O-tetradecanoylphorbol  13-acetate  (TPA) induced the ap- 
I. Abbreviations used in this paper: CMP sialic acid, cytidine monophos- 
phate siaiic acid;  H-buffer, homogenization buffer; HPTLC, high-perfor- 
mance thin-layer chromatography;  PNS, postnuclear  supernatant;  SPDP, 
(3-[2 pyridyodithio]-propionic acid N-hydroxysuccinimideester;  TPA, 12- 
O-tetradecanoylphorbol  13-acetate. 
pearance of significant amounts of Shiga toxin-binding sites, 
and the cells became sensitive to the toxin.  This has allowed 
us to study uptake and transport of Shiga toxin in polarized 
MDCK cells.  The results demonstrate that butyric acid-in- 
duced binding sites for Shiga toxin appear at both the apical 
and basolateral side of the MDCK cells and that the toxin 
is efficientiy internalized  from both sides. Furthermore, this 
glycolipid-binding  ligand is rapidly transported to the Golgi 
apparatus from both cell surface domains.  To our knowledge 
this is the first quantitative  study of the transport of a glyco- 
lipid-binding  ligand to the Golgi apparatus. 
Materials and Methods 
Materials 
HRP, pronase, diaminobenzidine, SPDP O-[2-pyridydithio]-propionic acid 
N-hydroxysuccinimideester),  asialofetuin, Hepes,  and Tris were obtained 
from Sigma Chemical Co., St. Louis, MO. Nycodenz was obtained from 
NYCOMED (Oslo, Norway); CMP[14C]sialic acid, [3H]leucine and Na125I 
were from the Radiochemical  Centre  (Amersham,  UK).  Neuraminidase 
(from  Vibrio cholera) was obtained  from Behring, (Marburg,  Germany). 
High-performance thin-layer chromatography (HPTLC) plates coated with 
Silica Gel 60 were purchased from E. Merck (Darmstadt, Germany). Stan- 
dard mixture of pure neutral glycolipids containing Gal~-lCeramidc (Cer) 
(CMH), Ga~-4Glc~-ICer(CDH), C~al-4Ga~-4GIc~-ICer(Gt~ICTHD, 
GalNAr/~I-3  Galal-4Galfll-4Glcfll-tCer(Gb4[GIA]),  GalNAro.I-3GaiNAc~I- 
3Gal~l-4Crdl/$1-4Glc/31-1Cer  (Forssman pentasaccaride)  was from BioCarb 
AB (Lurid, Sweden). Polyisobutylmethacrylate  was obtained from Plexi- 
Gum (Polysciences, Inc., Warrington, PA). Horse anti-Shiga toxin serum 
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was purified as previously described (7), and was a generous gift from Dr. 
J.  E.  Brown.  Conjugates of Shiga toxin and HRP were prepared by the 
SPDP method as previously described (46). 
Cells 
MDCK cells, strain I, were grown in Costar 3,000 flasks (Costar, Bad- 
hoevedorp/The Netherlands), or on polycarbonate filters (Costar Tram- 
well, pore size 0.4 #m, 24.5-mm diam). The cells were routinely seeded 
at a density of 106 per filter and used for experiments 2 to 5 d later (49). 
All filters used for experiments had a transepithelial resistance of at least 
1,000  ~  cm  2 as measured with the MilliceU-ERS equipment (Millipore 
Continental Water Systems, Bedford, MA, USA). The medium used was 
DME (3.7 g/1 sodium bicarbonate) (Flow Laboratories, Irvine, Ayrshire, 
Scotland) containing 5 % FCS (Gibco Laboratories, Ltd., Paisly, Scotland) 
and 2 mM L-glutamine (Gibco Laboratories). 
Formaldehyde Fixation and lsobutanol Extraction 
of CeUs 
Cell monolayers were incubated for 30 rain at 4°C with 1% formaldehyde 
in PBS with 2 mM CaCI2.  The cells were then washed twice in PBS and 
incubated for 10 rain at 250C with 50 mM NaBH4 in PBS. The cells were 
again washed in PBS, and when indicated, the cells were incubated for 10 
rain at 25°C with water saturated with isobutanol to extract lipids. At the 
end of this incubation the cells were again washed with PBS. 
Binding of Shiga Toxin to Isolated Glycolipids 
Total  neutral and acidic glycolipids from MDCK cells (1  x  1012 cells) 
grown as monolayers in plastic flasks were prepared as described by Haka- 
mori and Kanfer (18). The cells were lyophilized and extracted twice with 
10 vol (50 ml) of chloroform:methanol:water (4:8:3) overnight. Cell debris 
were removed by filtration through Whatman filter papers, the filtrates were 
pooled, and neutral and sialic acid containing glycolipids were separated 
using Folch partition (15). Samples were separated on Silica Gel 60 HPTLC 
plates using chloroform:methanol:water (60:35:8)  for neutral glycolipids 
and chloroform:methanol:0.2% CaCI2 (60:40:9) for acidic glycolipids, as 
mobile phases. Bands were visualized with 10%  sulfuric acid in ethanol. 
Highly purified t25I-labeled Shiga toxin was tested for binding to the pre- 
pared glycolipids (3). The air-dried chromatogram was soaked in 100 ml 
0.05% polyisobutylmethacrylale in hexane 3 x  1 rain, followed by incuba- 
tion in PBS supplemented with 1% BSA and 0.05% Tween 20 for 15 min. 
The plate was then incubated with 50 ml 20/~g/m1125I-labeled  Shiga toxin 
(280 cpm/ng) for 1 h, washed 5 times with 0.05%  Tween 20in PBS, air 
dried and exposed to X-OMAT X-ray film (Eastman Kodak Co., Rochester, 
NY) for 48 h. All incubations were performed at 20°C. 
Measurement of Cytotoxic Effect 
After incubation of cells with toxin as described in legends to figures, the 
medium was removed, and the cells were incubated in the same medium 
(no unlabeled leucine) for 10 rain at 37°C with 1 #Ci of [3I-l]leucine per 
ml. Then the solution was removed, the cells were washed twice with 5% 
(wt/vol) TCA and solubilized in KOH (0.1 M). Finally, the acid-precipitable 
radioactivity was measured. The experiments were carried out in duplicate. 
The difference between duplicates was <10%  of the average value. 
Measurement of Receptor-mediated Endocytosis 
of lzJ  i.Transferrin  and u5  I-Ricin 
The amount of internalized transferrin was measured as described by Cie- 
chanover (8). Endoeytosis of )~I-labeled ricin was measured as the amount 
of  toxin that could not be removed with lactose as previously described (36). 
Subcellular  Fractionation  of Polarized Cells Incubated 
with Shiga 7bxin 
125I-Shigeila toxin (1 #g/ml) was administered either to the apical or the 
basolateral medium of filler-grown MDCK I cell monolayers treated with 
butyric acid as described in the legend to Fig. 3. The toxin was continuously 
present during the incubation, and HRP was usually also added to label en- 
dosomal/lysosomal compartments. The incubations were carried out tech- 
nically as described by Bomsel et al. (5).  The incubations were terminated 
by cooling the cells, and all subsequent steps were carried out at 0-4°C. 
The fillers were cut out of their plastic holders, and washed 3  x  10 min 
in cold PBS/0.2% BSA with shaking. To each filter was then added 0.5 ml 
homogenization buffer (H-buffer; 0.3 M sucrose, 3 mM imidazole, pH 7.4), 
and the cells were scraped offthe fillers with a rubber policeman. Each filter 
was subsequently scraped once more and washed with 2 x  I mi of H-buffer. 
Cells from 3-6 filters were pooled for each experimental point. The pooled 
cells were pelleted by centrifugation for 10 min at 100 g. To the pellet was 
added H-buffer to 1 ml, it was resuspended and homogenized by passing 
it 10 times up and down through a  1-ml blue tip on a pipette (Gilson Co., 
Inc., Worthington, OH) followed by six times through a  1-mi syringe with 
a 22G 1 1/4 needle. The homogenate was centrifuged at 2,500 rpm for 10 
min in 1.5-ml tubes (Brinkman Instruments Inc., Westbury, NY) in a cen- 
trifuge (model 5415; Beckman Instruments, .Inc.) to obtain a nuclear pellet 
and a postnuclear supernatant (PNS). The PNS was subjected to discontinu- 
ous gradient centrifugation in a system similar to one applied by Sandberg 
et al. (35) to separate rat liver Golgi fractions from rough and smooth ER. 
In the bottom of SW 40 tubes, gradients were made of 4.5-ml light solution 
(1.15 M sucrose, 15 mM CsC1) and 1.5 mi heavy solution (1.15 M sucrose, 
15 rn_M CsC1, 15% Nycodenz [wt/vol]). The gradients were made in a Bio- 
comp Gradient Master (Nycomed, Oslo, Norway) (angle 74, speed 16, time 
2 rnin 45 s). PNS (5.6 parts) was mixed with 2 M sucrose, 10 mM CsC1 
(4.4 parts), usually a total of 1.5 mi, and layered on top of the gradient. 
This was again overlaid with 3 mi 0.9 M  sucrose, and finally 1-2  ml of 
0.3 M sucrose. After 4.5 h at 33,000  rpm, the gradients were fractionated 
(25-30 fractions) and analyzed with respect to marker distribution. The be- 
havior of MDCK cells in this system was characterized. 
Enzyme Analysis 
HRP was measured according to Sleinman et al. (45), UDP-galactose:gly- 
coprolein galactosyl transferase according to B~ndli et al. (6), esterase and 
fl-N-acetyl-glucosaminidase  according to Beaufay et al. (1), and sialyltrans- 
ferase according to Dall'Olio et al.  (10). 
Processing for EM 
MDCK cells grown in monolayers in T-25 flasks or on filters, were treated 
as described in the text, and fixed with 2 % glutaraldehyde in 0.1 M Na- 
cacodylate buffer, pH 7.2,  for 60 rain at room temperature. The ceils were 
then carefully washed with PBS  and incubated with diaminobenzidine- 
H202  as previously described (46).  The cells were postfixed with OsO4, 
treated with 1% uranyl acetate in distilled water, embedded in Epon, cut 
at 50 nm, and examined in an electron microscope (model 100 CX; JEOL 
USA, Electron Optics Div., Peabody, MA) without further contrasting as 
previously described (46). 
Results 
Induction of  Binding Sites for Shiga Toxin on MDCK 
Cells Grown on Impermeable Substrate 
Differentiation agents such as butyric acid, phorbol esters, 
retinoic acid and dimethylsulfoxide have been shown to pro- 
duce changes in the carbohydrate pattern at the cell surface 
(14, 31). We therefore tested whether such agents were able 
to induce synthesis of Shiga toxin-binding sites in MDCK 
cells. When MDCK cells grown on impermeable substrate 
were incubated with  increasing  concentrations of butyric 
acid for 48 h, the bufyric acid-treated cells were able to bind 
~2q-labeled Shiga toxin whereas untreated cells did not pos- 
sess this ability (Fig.  1 A). In agreement with this we found 
that while a Shiga-HRP conjugate (40) did not bind to con- 
trol MDCK cells, it distinctly labeled MDCK cells treated 
with 5 mM butyric acid (see Fig. 6 a). Maximal binding ('~6 
×  10  ~ toxin molecules/cell) was obtained with 5  mM bu- 
tyric acid. 
The appearance of Shiga toxin receptors at the cell surface 
appears to be dependent on the synthesis of new receptors 
since cycloheximide blocked the butyric acid-mediated in- 
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Figure 1. Effect of short-chain fatty acids, TPA, and DMSO on the binding of t25I-labeled  Shiga toxin to MDCK cells. MDCK cells grow- 
ing in 24-well disposable trays were incubated for 48 h in bicarbonate-containing medium with 10% FCS in the presence of increasing 
concentrations of butyric acid (A), or with vaieric and propionic acid, and with different concentrations of TPA and DMSO (B). The cells 
were then incubated with 125I-labeled Shiga toxin (0.2 ml with 120 ng/ml; 5900 cpm/ng) for 20 min at 37°C in a Hepes-containing 
medium with 5 % serum. Then the cells were washed three times in ice-cold PBS, they were dissolved in KOH (0.1 M), and the radioactivity 
was measured. The deviations between duplicate measurements were <10%. 
duction of Shiga toxin binding (data not shown).  Probably 
cycloheximide inhibited synthesis of enzymes required for 
glycolipid synthesis. Also, treatment of noninduced MDCK 
cells with pronase to expose possible "cryptic" glycolipids at 
the cell surface did not reveal any binding sites for the toxin. 
Also the fatty acids valeric acid and propionic acid in- 
duced the appearance of binding sites for Shiga toxin, al- 
though to a lesser extent than butyric acid. Butyric acid, in 
contrast to hydroxybutyric and acetoacetic acid, is reported 
to induce hyperacetylation of histories (42), a phenomenon 
which may be related to some of the effects of butyric acid. 
We therefore tested whether these related compounds were 
able to induce appearance of Shiga toxin binding sites.  As 
shown in Fig.  1 B that was not the case. 
Of the other differentiation agents tested, only the phorbol 
ester TPA induced binding of 125I-Shiga toxin, although to a 
smaller extent than butyric acid. TPA and butyric acid to- 
gether gave no additive effect (data not shown), suggesting 
that the compounds act at least partially through the same 
pathway.  The inactive phorbol ester phorbol 12-myristate, 
13-acetate, 4-O-methylether, and the compounds dimethyl- 
sulfoxide (1%), retinoic acid (10  -5 M), and dexamethasone 
(20-250 #M) did not induce any binding of Shiga toxin to 
MDCK cells (Fig.  1 B and data not shown). 
We next measured the time course for the butyric acid and 
TPA-induced appearance of Shiga toxin receptors. As shown 
in Fig. 2, no binding.could be measured until 18-20 h after 
addition of either of the two compounds regardless of the 
concentrations used. The binding then increased rapidly and 
leveled off after '~36 h. 
Binding of Shiga Toxin to Polarized MDCK Cells 
Grown on Filters 
As described for MDCK cells grown on a plastic surface, 
filter-grown MDCK cells did not bind detectable amounts of 
Shiga  toxin.  We therefore decided to  test whether Shiga 
toxin-binding sites could be induced in filter-grown MDCK 
cells after they had formed tight junctions (resistance higher 
than 1,000 fl cm2), and whether the receptors appeared on 
both sides of the cells. The experiments revealed that when 
1-2 mM butyric acid was added shortly after formation of 
a cell layer with the required electrical resistance, the cells 
did express binding sites for Shiga toxin both apically and 
basolaterally without loss of electrical resistance (data not 
shown). At higher concentrations of butyric acid the electri- 
cal resistance was strongly reduced. When the cells were in- 
cubated with Shiga toxin (2 #g/ml) for 1 h at 0°C or for 20 
min at 37°C, ~2  x  105 molecules were bound per cell. The 
amount of toxin bound basolaterally was  1.6 times higher 
than the amount bound apically (data not shown). Consider- 
ing the larger surface area of the basolateral side (a factor 
of 3-6) (30), this implies a higher density of binding sites 
at the apical side. When MDCK cells were incubated with 
butyric acid before they were plated on filters (Fig. 3), simi- 
lar amounts of Shiga toxin was bound as when butyric acid 
was added to filter-grown cells. This method was used to ob- 
tain binding sites for Shiga toxin in the fractionation studies 
shown below, since it was more reproducible. The phorbol 
ester TPA can not be used to induce synthesis of  binding sites 
for Shiga toxin in filter-grown cells since it rapidly abolishes 
the electrical resistance across the cell layer (28). 
Properties of the Shiga Toxin Binding Sites 
on MDCK Cells 
The functional Shiga toxin binding sites on sensitive cells 
studied so far have proved to be glycolipids (9, 40; MObas- 
saleh, M., A. Donohue-Rolfe, R. Montgomery, G. Keusch, 
and R. Grand. 1986. Pediatr. Res. 20:a245.). To investigate 
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Figure 2. Time course for the ap- 
pearance  of Shiga toxin binding 
sites upon addition of  butyric acid 
and TPA. MDCK cells growing 
in 24-well disposable  trays were 
incubated  in  a bicarbonate-con- 
taining  medium  with  10%  FCS 
with  and  without  the  indicated 
concentrations  of  butyric  acid 
(A) or TPA (B).  After the indi- 
cated periods of time the binding 
of 125I-labeled Shiga toxin to the 
cells was measured as described 
in the legend to Fig.  1. 
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Figure 3. Development of electrical resistance and binding of Shiga 
toxin  to butyric acid-treated MDCK cells  growing on polycar- 
bonate filters. MDCK cells were incubated with 2 mM butyric acid 
in flasks for 48 h. The cells were then trypsinized,  transferred to 
fresh medium containing  1 mM butyric acid, and plated on filters. 
Binding of L2SI-labeled Shiga toxin to the cells was measured both 
at the time when the cells were transferred to the filters and after 
increasing time when growing on the filters.  The cells were in- 
cubated for 20 min at 37°C in the presence of toxin (1,500 ng/ml; 
685 cpm/ng),  they were then washed three times in ice-cold PBS 
and the cell-bound radioactivity was measured. Also the electrical 
resistance across the filters was measured after different periods of 
incubation.  (o), Cell-bound toxin;  (x), electrical resistance. 
if that was the case also in MDCK cells, we treated cells with 
butyric acid-induced binding sites with pronase. If the bind- 
ing sites were glycoproteins, the pronase treatment should 
abolish the binding. However, as shown in Table I, pronase 
treatment did not decrease, but rather slightly increased the 
binding of ~25I-labeled Shiga toxin to the cells,  suggesting 
that also on MDCK cells the toxin is bound to glycolipids. 
Similar results were obtained with filter-grown MDCK cells. 
Furthermore, extraction of glycolipids from formaldehyde- 
fixed cells almost completely removed the toxin binding sites 
(Table I). We were also able to demonstrate that t25I-Shiga 
toxin binds to glycolipids extracted from MDCK cells only 
after treatment of the cells with butyric acid (Fig.  4). 
The lipids were separated on a thin-layer chromatogram, 
and binding of toxin was revealed by autoradiograpby. In the 
neutral  glycolipid fraction from butyric acid-treated cells 
Shiga toxin was found to bind to two closely migrating gly- 
colipids with approximately the same Rf value as for globo- 
trialylceramide (Fig. 4 b, lane 3). Globotriasylceramide was 
the only glycolipid in the standard mixture of neutral gly- 
colipids which bound the toxin. No binding of toxin to sialic 
acid-containing glycolipids was detected (data not shown). 
Shiga toxin binds the structure gal otl-4 gal (9,  Mobas- 
saleh, M., A. Donohue-Rolfe, R. Montgomery, G. Keusch, 
and R. Grand.  1986.  Pediatr.  Res. 20:a245).  Sialylation of 
this structure might reduce the binding of toxin. We there- 
fore treated butyric acid-induced MDCK cells with neur- 
aminidase. As shown in Table I the enzyme treatment almost 
doubled the binding of toxin to the cell surface, suggesting 
that removal of sialic acid from galactose indeed revealed 
additional binding sites.  Control experiments showed that 
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and Lipid-extraction on the Binding of 1251-Shiga Toxin 
to Butyric Acid-Treated MDCK Cells 
Treatment  Toxin bound (% of control) 
None  100 
Pronase*  179 
Fixed and isobutanol-treated cells*  4 
Neuraminidase§  188 
* MDCK cells growing on plastic and incubated with butyric acid (5 raM) for 
48 h were incubated with pronase (1 mg/ml) for 15 min at 37"C. The cells were 
then transferred to Eppendorf tubes (Brinkman Instruments,  Inc.) spun down, 
and resuspended in 1 ml Hepes medium with 10% serum and ~25I-Shiga  toxin. 
After  20-min incubation  at 37°C, the cells were washed twice and the cell- 
associated radioactivity  was measured. 
Ceils growing in 24-well disposable trays were incubated for 48 h with bu- 
tyric acid (5 rnM), fixed with formaldehyde,  and extracted with isobutanol as 
described in Materials and Methods. Both untreated and treated cells were then 
incubated with ~251-Shiga toxin for 20 rain at 37°C, washed twice with PBS, 
and finally the amount of bound toxin was measured. 
§ Cells incubated with butyric  acid (5 mM) for 48 h were treated with neu- 
raminidase (0.1 U) for 30 min at 37°C. Then binding of ~25I-Shiga toxin was 
measured as described  above. 
neuraminidase treatment did not reveal any binding sites for 
Shiga toxin on MDCK cells not incubated with butyric acid. 
That the butyric acid-induced synthesis of Shiga toxin recep- 
tors also in MDCK cells involves addition of galactose to 
surface structures is supported by the finding that there is no 
induction of Shiga toxin receptors in a mutant MDCK cell 
line with a reduced number of galactose residues on the cell 
surface (data not shown). 
Figure 4.  Binding of ~25I-Shiga toxin to glycolipids.  Glycolipids 
from MDCK ceils were extracted and separated on HPTLC plates 
as described in Materials and Methods. (a) HPTLC pattern of  total 
neutral glycolipids from MDCK ceils grown without butyric acid 
(lane 1 ), and with 5 mM butyric acid for 48 h (lane 2).  Lane 3 
shows a  standard  mixture  of glycolipids containing  pure mono- 
hexylcerarnide (CMH), galabiosylceramide (CDH), globotriasyl- 
ceramide (CTH),  Globoside (Gb4 (GL4)) and Forssman pentasac- 
charide. In b is shown an autoradiogram of the binding of ~zsI-Shiga 
toxin  to the  same glycolipids.  The binding  experiment  was per- 
formed as described  in Materials  and Methods. 
"o 
oo 
o 
e- 
uo 
T 
100 
80 
60 
40 
20 
I  I  I  I  I 
\',, 
48h  with  b./aa/~  ~ 
\\ 
I  I  I  I  I 
0.1  1  10  100  1000 
Toxin  concentration  (ng/ml) 
Figure 5. Effect of butyric acid on the sensitivity of MDCK cells 
to Shiga toxin. MDCK cells growing in 24-weU disposable trays in 
bicarbonate-containing  medium with  10%  FCS  were  incubated 
with and without butyric acid (5 mM) for the indicated periods of 
time. Then increasing concentrations of  Shiga toxin were added and 
the protein synthesis was measured as described  in Materials and 
Methods 3 h later. 
Intoxication of  Butyric Acid-treated MDCK Cells 
Shiga toxin inhibits protein synthesis in a limited number of 
cell lines. Even cells that possess binding sites for the toxin 
may be completely resistant (12).  To test whether MDCK 
cells treated with butyric acid are sensitive to Shiga toxin, 
we  incubated  the  cells with  5  mM butyric acid  and  then 
added Shiga toxin after increasing periods of time. After 3 h 
in the presence of toxin we measured the protein synthesis. 
As shown in Fig. 5, the cells were resistant when toxin and 
butyric  acid  were added  simultaneously.  Also,  when  the 
toxin was added 3 h later than butyric acid, the cells were 
still resistant.  However, when the cells had been incubated 
for 24 or 48 h with butyric acid they were intoxicated upon 
addition of toxin. The sensitizing effect of butyric was revers- 
ible. Cells treated with butyric acid became resistant to the 
toxin 24 h after removal of the fatty acid (data not shown). 
The results therefore indicate that the new binding sites ob- 
tained are functional in the sense that they mediate the trans- 
location of Shiga toxin to the cytosol. 
Endocytosis and lntraceUular Traffic of Shiga Toxin 
in MDCK Cells 
We have previously shown that Shiga toxin in toxin-sensi- 
tive HeLa cells is internalized by the coated pit/coated vesi- 
cle pathway in spite of being bound to glycolipid receptors 
in sensitive cells (40). The internalization of Shiga-HRP in 
MDCK cells treated with butyric acid appears to occur in 
a  similar way.  Thus,  as  shown in Fig.  6,  Shiga-HRP was 
evenly distributed at the cell surface at 4°C. Upon warming 
the cells to 37°C, a marked redistribution of Shiga-HRP oc- 
curred. The toxin was rapidly internalized in coated pits and 
Sandvig et al. Binding and Intracellular Transport of Shiga Toxin  557 Figure 6.  Labeling of butyric acid (5 mM)-treated MDCK cells with Shiga-HRP. In a cells were incubated with Shiga-HRP at 4°C, and 
a uniform labeling (HRP reaction product) is seen on the cell surface. In b and c ceils were incubated with Shiga-HRP at 4°C, and thereafter 
washed and further incubated for 15 rain at 37"C. In this situation surface labeling is reduced or absent whereas coated pits and/or vesicles 
(arrows) are heavily labeled. The cells were grown on plastic. Bars: (a)  1 #m; (b) 0.25 #m; and (c) 0.5 #m. 
vesicles (Fig.  6).  That Shiga toxin was endocytosed from 
coated pits algo  in MDCK cells was as earlier shown for 
HeLa cells (40) supported by the finding that acidification of 
the  cytosol,  which  inhibits  endocytosis from coated pits 
(38), protected the cells against the toxin (data not shown). 
After 15-60-min incubation with Shiga-HRP at 37°C, reac- 
tion product was distinct in endosomes and lysosomes (Fig. 
7). Also Golgi profiles with distinct reaction product could 
be observed (Fig. 7). 
Butyric acid treatment of cells has been reported to cause 
morphological changes 07, 22). We therefore tested whether 
treatment of MDCK cells with butyric acid had any effect on 
the rate of clathrin-dependent and clathrin-independent en- 
docytosis. To monitor these two processes we measured the 
uptake of transferrin, ricin, and HRP. Transferrin is known 
to be internalized from coated pits, whereas ricin and fluid 
phase markers seem to be endocytosed also by a clathrin- 
independent mechanism (38, 39, 41). HRP uptake was mea- 
sured both at the apical and the basolateral side of filter- 
grown MDCK cells. We observed no changes in the uptake 
of these markers for endocytosis (data not shown), suggest- 
ing that butyric acid does not affect endocytosis as such. 
To study the intracellular traffic of t25I-Shiga toxin in a 
quantitative  way, we applied subcellular fractionation methods 
to polarized cells incubated with the t25I-labeled toxin and 
measured the mount of  toxin associated with the various in- 
traceUular organelles. In this discontinuous gradient system 
the PNS is mixed with a heavy solution and is positioned in 
the middle of the tube before centrifugation. The load zone 
is overlayered  by a 0.9 M sucrose layer, which is again over- 
layered by a 0.3 M sucrose layer (see Materials and Methods). 
Organelle markers separated in three reproducible peaks. 
Most of the galactosyl- and sialyltransferase activity moved 
upward in the gradient to the 0.9 M/0.3 M sucrose interfase 
The Journal of Cell Biology, Volume 113,  1991  558 Figure  7. Endocytosis of Shiga-HRP in butyric acid (5 mM)-treated  MDCK cells. In a, labeled endosome-like vacuoles (En) are seen, 
after 15 min at 37°C, and in b is shown a labeled Golgi complex (Go) next to the nucleus (Nu), after 60 min at 37°C. a and b, cells grown 
on plastic. In c butyric acid-treated cells grown on a filter have been incubated with Shiga-HRP from the apical surface for 90 min. The 
apical (Ap) plasma membrane is unlabeled whereas a lysosome-like vacuole (Ly) is heavily labeled. In d butyric acid-treated MDCK cells 
on a filter were incubated for 90 min with Shiga-HRP from the basal side. A portion of the filter is seen (Fi). Both endosome-like (En) 
and lysosome-like (Ly) vacuoles are present.  Bar, 0.5 #m. 
(peak I in Fig. 8), indicating that the Golgi apparatus compo- 
nents could be recovered from this part of the gradient. 
A second peak of enzyme activity (peak II in Fig. 8) re- 
mained in the load zone. This part of the gradient contained 
markers released from disrupted endosomes and lysosomes 
during  homogenization (HRP  from endosomes  and  B-N- 
acetyl-galactosaminldase from lysomes) as well as plasma 
membrane-bound toxin (verified by fractionation of cells 
with toxin bound at 0°C). From these experiments it could 
be calculated that only 0.2 % of  the plasma membrane-bound 
toxin was recovered in the Golgi-rich fractions. Thus, our 
measurements of Shiga toxin transport to the Golgi appara- 
tus are not affected by contamination by plasma membrane. 
Peak 1/I in Fig.  8 contained a number of organdies that 
had moved downward into the heavy gradient. Endosomes 
(loaded with HRP),  lysosomes (/~-N-acetyl-galactosamini- 
dase), and ER (esterase) were found in this peak. All classes 
of endosomes were found in this position (Fig. 8), early api- 
cal endosomes as revealed by the location of HRP in cells 
incubated with this enzyme for 10 rain at 37°C, early baso- 
lateral endosomes (labeled in the same way), and late endo- 
somes (the cells were incubated with HRP for 10 rain at the 
apical or basolateral side followed by a 40-rain chase without 
HRP).  Also after 2-h- continuous incubation with HRP at 
37°C this peak was labeled. Typically, the recovery of HRP 
within organelles was 60%  after homogenization and cen- 
trifugation, while 80%  of the lysosomes were intact.  The 
maximal contamination of the Golgi enriched fractions of 
these gradients was 0.4% of the total cell-associated HRP 
and 0.8 % of the total cell-associated marker/~-N-acetyl-glu- 
cosarninidase. These contaminations could either represent 
molecules released during fractionation and sticking to Gol- 
gi membranes, or they could represent intact organdies. In 
any case, the contaminations are too small to affect  our quan- 
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Figure 8. Distribution of Shiga toxin, HRP, and organelle markers 
in a discontinuous sucrose/Nycodenz  gradient system. Filter-grown, 
butyric acid-treated  (see legend to Fig. 3) MDCK cells were in- 
cubated apically with mI-Shiga toxin (1 ~g/ml;  10,000 cpm/ng) 
and HRP (3 mg/ml) for 60 min at 37°C (A), basolaterally for 10 
min with HRP (B), or basolaterally for 10 min with HRP followed 
by a 40-rain chase in HRP-free medium (C). (A): (A), 125I-Shiga 
toxin; (o),/~-N-Acetylglucosaminidase; (o), HRP, 60 min at 37°C 
apically. (B): (zx), HRP, 10 min basolaterally; (+), UDP-galacto- 
syltrausferase. (C):  (v), HRP, 10 min plus 40-min chase basolat- 
erally; (+), sialyltrausferase. 
titative results.  We verified that incubation of filter-grown 
cells with butyric acid had no effect on the localization of the 
different organelles in the gradients. 
By using this system we were able not only to measure the 
amount of Shiga toxin transported to the Golgi apparatus af- 
ter different periods of time, but also to study whether this 
glycolipid-binding ligand is transported to the same extent 
to the Golgi apparatus  when added at the apical and the 
basolateral side of the cells. A typical experiment where the 
ceils were incubated with Shiga toxin and HRP simultane- 
ously for 1 h at 37°C is shown in Fig.  8.  The experiment 
shows that Shiga toxin was found at the plasma membrane, 
in endosomes/lysosomes and in the Golgi fractions, whereas 
no HRP was detected in the Golgi apparatus. Furthermore, 
the  experiments showed that Shiga toxin was  transported 
rapidly to the Golgi compartment from the apical and the 
basolateral side of the cell monolayer, the transport being 
equally efficient from the two sides (Fig. 9). As shown, Shiga 
toxin was found in the Golgi apparatus already after 15 min, 
and the fraction associated with this organelle increased with 
time. The fraction of endocytosed toxin transported to the 
Golgi apparatus can be estimated by subtracting the amount 
of toxin found in the  load zone,  presumably membrane- 
bound toxin.  Expressed in this  way the fraction of toxin 
transported to the Golgi apparatus after 1 h at 37°C was 10% 
after basolateral addition and 11% after apical addition. 
It has earlier been shown for several cell types that there 
is little or no transport from the cell surface to the Golgi ap- 
paratus at temperatures below 18-20°C (37, 47, 48). In agree- 
ment with this,  we found a  strongly reduced transport of 
Shiga toxin to the Golgi apparatus at low temperatures (Fig. 
10).  The amount of Shiga toxin in the gradients represents 
essentially all the internalized toxin since there is almost no 
degradation of toxin (measured as nonprecipitable radioac- 
tivity) during a 2-h incubation period (data not shown). 
Discussion 
The results show that functional binding sites for Shiga toxin 
in MDCK cells can be induced by incubation of  the cells with 
butyric acid and TPA. As earlier shown for other cell types 
(9, 20, 23, 40; Mobassaleh, M., A. Donohue-Rolfe, R. Mont- 
gomery, G. Keusch, and R. Grand.  1986. Pediatr. Res. 20: 
a245.) also the binding sites in MDCK cells seem to he gly- 
colipids. We were able to show that butyric acid induced syn- 
thesis of neutral glycolipids that bind Shiga toxin. Further- 
more, the binding  sites  were removed upon extraction of 
glycolipids with butanol but not by pronase treatment. The 
importance of the galactose residues was supported by the 
finding that neuraminidase treatment increases the binding 
and that a mutant cell line with a reduced number of terminal 
galactose residues was unable to synthesize binding sites for 
the toxin upon addition of butyric acid.  Interestingly, the 
binding sites were able to mediate transport of the toxin to 
the cytosol where the toxin inhibits the protein synthesis en- 
zymatically and thereby kills the cell (33). 
It has been shown that differentiation agents such as bu- 
tyric acid, phorbol esters, and retinoic acid may change the 
glycosylation pattern at the cell surface (2,  13,  14,  31).  As 
shown here, only butyric acid and TPA induced synthesis of 
Shiga toxin-binding sites in MDCK cells. Retinoic acid and 
DMSO  (27)  had no effect. Also dexamethasone has been 
shown to affect glycosyltransferase activities (51) and to in- 
terfere with the action of butyrate and TPA (16, 32, 44), but 
it was unable to induce synthesis of Shiga toxin-binding sites 
in MDCK cells. Butyric acid has been found to modulate the 
expression of a number of genes (13, 14, 19, 25, 31, 32, 34). 
This could be because of its ability to cause changes in phos- 
phorylation of nuclear proteins (4,  11), changes  in DNA 
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Figure  9.  Transport  rate  of Shiga 
toxin from the apical and basolateral 
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ing periods of time as described in 
Materials and Methods. (o), apical 
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addition. The  bars represent the range 
of variation between three different 
experiments. 
methylation (29), or hyperacetylation of histones (42). It is 
not clear whether such changes are involved in the induced 
synthesis of Shiga toxin-binding sites here observed, but 
hydroxybutyric  acid and acetoacetic acid which are both un- 
able to induce hyperacetylation of histones were also unable 
to induce synthesis of Shiga toxin-binding sites.  As shown, 
both propionic acid and valeric acid which also in other sys- 
tems affect cells in a similar way as butyric acid (25) induced 
synthesis of Shiga toxin-binding sites. 
We have earlier shown that Shiga toxin in spite of being 
a  glycoplipid-binding ligand  is  internalized by the coated 
pit/coated vesicle pathway (40). As shown here this appears 
also to be the case in MDCK cells. It is not understood how 
glycolipids can be induced to aggregate in coated pits. It was 
recently shown that also glucosylceramide seems to be inter- 
nalized from clathrin-coated pits (21), suggesting that lipids 
can be internalized by this pathway also without being cross- 
linked with a ligand such as Shiga toxin. 
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Figure 10. Effect of temperature on the amount of Shiga toxin trans- 
ported to the Golgi apparatus. Butyric acid-treated  MDCK cells 
(see Fig. 3) were incubated with 125I-Shiga toxin (1 t~g/ml; 10,000 
cpm/ng) added apically or basolaterally for 60 min at the indicated 
temperature.  The cells were subsequently washed and homoge- 
nized as described in Materials and Methods. 
We have earlier observed that a Shiga-HRP conjugate is 
transported to the Golgi apparatus of sensitive cells (40). As 
shown here this was also the case after induction of Shiga 
toxin-binding sites in MDCK cells. Similarly, a fluorescent 
analogue of glucosylceramide was found to be transported 
to the Golgi apparatus in BHK cells (21). However, in none 
of these studies was the amount of lipid transported to the 
Golgi apparatus quantified. Since Shiga toxin can be used as 
a marker for the transport of its glycolipid-binding sites, we 
therefore used ~25I-labeled Shiga toxin and subcellular frac- 
tionation to determine the amount of toxin transported to the 
Golgi apparatus.  Furthermore, we used polarized cells to 
test whether toxin internalization and the subsequent trans- 
port to the Golgi apparatus were equally efficient when the 
toxin was added apically and basolaterally. Interestingly our 
data demonstrate that Shiga toxin not only bound to both 
sides of the polarized cells, but it was rapidly internalized 
and transported to the Golgi apparatus from both the apical 
and  the  basolateral  surface of the cells.  Our quantitative 
studies with cell fractionation revealed that ca.  10% of the 
ceU-associated Shiga toxin reached the Golgi complex after 
60-min incubation at 37°C. We have previously found a simi- 
lar figure, ca. 5 %, for ricin reaching the Golgi complex in 
BHK ceils (48). However, in contrast to Shiga toxin which 
binds only to glycolipids, ricin binds to both glycoproteins 
and glycolipids with terminal galactose. 
That a higher amount of Shiga toxin was bound per surface 
area at the apical than at the basolateral side of the cells is 
in agreement with earlier measurements of the distribution 
of glycolipids in these ceils (26, 43, 50). Whether glycolipids 
are normally excluded from coated pits to preserve the un- 
even distribution at the two poles of the cell is not known. 
However, our data strongly suggest that glycolipids can be 
efficiently transported to the Golgi apparatus from both sides 
of a polarized epithelial cell. 
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